Today, Vicebio, a UK-based vaccine company completed a $100 million series B round led by TCGX with investments from Goldman Sachs Alternatives, Avoro Ventures, venBio, and participation from UniQuest and founding investor Medicxi. With its molecular clamp technology...
Credit: Unsplash/CC0 Public Domain The most frequently used mpox vaccine provides partial immunity to the disease but isn’t always able to prevent severe symptoms or disease transmission. A new vaccine candidate from Moderna, mRNA-1769, more effectively limits...
Graphical abstract. Credit: Cell (2024). DOI: 10.1016/j.cell.2024.07.052 As researchers estimate that nearly all Americans have been exposed to SARS-CoV-2, the virus that causes COVID-19, whether through infection or vaccination, we are no longer...
As COVID-19 settles into a permanent presence in our lives, annual vaccinations are becoming the norm. Earlier this month, an official from the Centers for Disease Control and Prevention (CDC) declared COVID-19 “endemic,” indicating that the virus is here...
Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced the launch of an...
